FXR agonist 4 is a small molecule activator of the Farnesoid X receptor (FXR) with an EC50 of 1.05 µM. It has demonstrated efficacy in preclinical models, improving metabolic parameters such as hyperlipidemia, hepatic steatosis, and insulin resistance in diet-induced obese mice, supporting its research application in NAFLD/NASH.
Molecular Weight:
373.92
Formula:
C21H28ClN3O
Target:
FXR,Others
* VAT and and shipping costs not included. Errors and price changes excepted
